Serious games tested as Cost-Effective therapy for Alzheimer's
NCT ID NCT03208491
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether special video games (serious games) that combine physical and mental exercises are a good value for managing Alzheimer's disease. About 136 people with mild to moderate Alzheimer's will either play these games with a therapist or receive usual care. Researchers will compare costs and quality of life to see if the games are worth using more widely.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- serious games (cognitive and physical workouts)
- What this could lead to
- If it works, this could show that serious games are a cost-effective way to help manage Alzheimer's symptoms and improve quality of life.
- What could go wrong
- This is a mid-stage economic study, not a treatment trial. The games may not provide meaningful benefits, and results may not apply to all patients or care settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 136 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2017
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male or Female ≥ 60 years of age; * Subjects diagnosed with Alzheimer's Disease or related disorders associated with mild to moderately severe (CIM 10) * a score between 12 and 24 on the Mini Mental score evaluation * Subject treated in one of the participating centers * To have the social welfare insurance * Signature of the free and informed consent in the case of a patient under guardianship with signature of the guardian Exclusion Criteria: * history of epilepsy * major walking or balance disorder. * Subject without freedom by judicial or administrative decision
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alzheimer disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nice
Nice, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a massive data registry crack the code of Parkinson's and related brain diseases?
- Can a gentle electric current calm the mind in Alzheimer's?
- Alzheimer's vaccine aims to clear amyloid before memory fades
- Blood, eye, and brain scans team up to spot Alzheimer's earlier
- Can a home device slow Alzheimer's? pilot study tests pulsed electromagnetic therapy
- Eye scans as a window to the body: study probes retinal imaging across diseases